Costa, I. et al. 2022. Metastatic Castration-Resistant Prostate Cancer with BRCA2 Mutation: The Challenge Incorporating PARP Inhibitors and Platinum in Treatment Sequencing. European Journal of Case Reports in Internal Medicine. 9, 5 (May 2022). DOI:https://doi.org/10.12890/2022_003331.